Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NKTR
#1880
Nektar Therapeutics - Common Stock
67.1
0
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.84%
Monthly Change
-10.65%
6 month change
-8.08%
Year Change
-8.42%
Previous Close
68.3
6
Open
67.1
0
Low
67.1
0
High
67.1
0
Volume
311
Markets
US Stock Market
Healthcare
Biotechnology
NKTR
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
12.15 M
12.42 M
12.62 M
12.24 M
12.41 M
28.69 M
34.14 M
Valuation ratios
Enterprise value
2.9 B
2.49 B
326.2 M
73.94 M
128.82 M
1.2 B
2.33 B
Price to earnings ratio
-6.83
-4.72
-1.11
-0.41
-1.6
-4.35
-11.19
Price to sales ratio
19.85
24.3
4.45
1.25
1.94
12.91
26.12
Price to cash flow ratio
-9.69
-6
-1.35
-0.59
-1.09
-3.42
-6.61
Price to book ratio
2.82
3.64
1.12
0.86
3.15
7.94
1.15
Enterprise value to EBITDA ratio
-7.02
-5.75
-0.9
-0.29
-1.27
-8.23
-15.63
Profitability ratios
Return on assets %
-0.29
-0.47
-0.52
-0.69
-0.39
-0.59
-0.04
Return on equity %
-0.41
-0.77
-1
-2.11
-1.96
-1.83
-0.04
Return on invested capital %
-255.29
-427.27
-540.74
-747.1
-563.62
-1 616.68
-58.89
Gross margin %
87.26
75.57
76.5
62.53
68.82
100
100
Operating margin %
-278
-437.76
-408.63
-292.59
-106.88
-253.66
-417.94
EBITDA margin %
-269.83
-425
-395.38
-284.82
-102.71
-263.64
-453.17
Net margin %
-290.65
-514.03
-399.98
-306.31
-120.86
-297.07
-400.97
Liquidity ratios
Quick ratio
9.7
9.15
7.72
6.14
4.26
4.97
—
Current ratio
9.83
9.34
8
6.45
4.26
4.97
10.42
Inventory turnover
1.39
1.6
1.24
1.91
3.81
—
—
Asset turnover
0.09
0.08
0.1
0.16
0.28
0.2
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-26.31
-33.77
-24.37
-15.21
-12.82
-12.36
-10.51
EBIT per share
-35.71
-36.51
-30.15
-20.82
-7.67
-8.3
-6.17
EBITDA per share
-34.66
-35.44
-29.17
-20.26
-7.37
-8.63
-6.53
Total debt per share
—
—
—
—
—
—
—
Cash per share
89.19
60.06
40.48
23.97
18.62
14.57
20.7
Net current asset value per share
95.59
65.11
43.76
26.11
19.06
15.78
22.37
Tangible book value per share
90.49
55.61
29.39
10.34
4.43
5.32
27.32
Working capital per share
85.86
58.13
38.3
22.06
14.58
12.61
20.22
Book value per share
90.49
55.61
29.39
10.34
4.43
5.32
27.32
News
Nektar Q2 Earnings Beat Estimates, Revenues Lag, Pipeline in Focus
Retail Sales Weaken in July
U.S. Stock Futures Mixed, Heads for a Winning Week
Nektar Therapeutics (NKTR) Reports Q2 Loss, Misses Revenue Estimates
Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates
Does Nektar (NKTR) Have the Potential to Rally 104.06% as Wall Street Analysts Expect?
Nektar: Sanofi’s Exit Clears A Competitor But Raises The Bar In Atopic Dermatitis (NKTR)
NKTR Up on Start of Phase III Program on Rezpeg for Atopic Dermatitis
Why I'm Still Neutral On Nektar Therapeutics After Alopecia Areata Extension Data (NKTR)
Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concern
5 Healthcare Stocks Set to Join the Russell 3000 - TipRanks.com